| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/2011 | WO2011049475A1 The new application of 2-pyrrolidone derivatives |
| 04/28/2011 | WO2011049474A1 Salts of imatinib with tartaric acids |
| 04/28/2011 | WO2011049400A2 Pharmaceutical composition containing acid addition salt of n,n-dimethyl imidocarbonimidic diamide for anti-cancer |
| 04/28/2011 | WO2011049348A2 Antiviral agents obtained from curcuma longa, having inhibitory activities against avian influenza, swine influenza, and novel influenza |
| 04/28/2011 | WO2011049344A2 Method of preparing sitagliptin and intermediates used therein |
| 04/28/2011 | WO2011049332A2 2,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors |
| 04/28/2011 | WO2011049274A1 Imidazole derivatives and compositions for treating melanoma |
| 04/28/2011 | WO2011049213A1 Fused heterocyclic compound and thrombopoietin receptor activator |
| 04/28/2011 | WO2011049191A1 Pharmaceutical composition for oral administration |
| 04/28/2011 | WO2011049155A1 Process for production of quinuclidine compounds |
| 04/28/2011 | WO2011049127A1 5-hydroxypyrimidine-4-carboxamide derivative having hydrocarbon ring group |
| 04/28/2011 | WO2011049126A1 5-hydroxypyrimidine-4-carboxamide derivative |
| 04/28/2011 | WO2011049122A1 Pravastatin sodium tablet rapidly disintegrating in oral cavity and method for producing same |
| 04/28/2011 | WO2011049093A1 Film-coated tablet which is suppressed in discoloration and odor |
| 04/28/2011 | WO2011049059A1 Composition comprising rna-enclosing carrier |
| 04/28/2011 | WO2011049058A1 Water-based paste containing diclofenac sodium |
| 04/28/2011 | WO2011049042A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient |
| 04/28/2011 | WO2011049038A1 Transdermally absorbable donepezil-containing preparation |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011048806A1 Agent for improving sperm motility, agent for improving fertility, method for improving sperm motility and method for improving fertility |
| 04/28/2011 | WO2011048617A2 Extracts, fractions and compositions comprising acetogenins and their applications |
| 04/28/2011 | WO2011048611A1 Novel fused pyridazine derivatives |
| 04/28/2011 | WO2011048601A1 Treatment of scarred heart tissue by a chemical peeling composition |
| 04/28/2011 | WO2011048564A2 Orally disintegrating tablets of flurbiprofen |
| 04/28/2011 | WO2011048563A2 Orally disintegrating tablets of betahistine |
| 04/28/2011 | WO2011048557A1 Orally disintegrating tablets of memantine |
| 04/28/2011 | WO2011048554A2 Combination of a probiotic lysate and a c-glycoside derivative |
| 04/28/2011 | WO2011048553A2 Pharmaceutical compositions of pde-5 inhibitors and dapoxetine |
| 04/28/2011 | WO2011048525A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators |
| 04/28/2011 | WO2011048514A1 Derivatives of n-hydroxybenzamide for treating hiv infections |
| 04/28/2011 | WO2011048496A1 Triptans for the treatment of psoriasis |
| 04/28/2011 | WO2011048493A1 Coated capsules and tablets of a fatty acid oil mixture |
| 04/28/2011 | WO2011048479A2 Compositions that include anthocyanidins and methods of use |
| 04/28/2011 | WO2011048409A1 Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/28/2011 | WO2011048245A1 Use of a spirolide, analogues and derivatives for treating and/or preventing pathological conditions linked to the tau and beta-amyloid proteins |
| 04/28/2011 | WO2011048210A1 PDGFR-α AS RESPONSE MARKER FOR PM00104 TREATMENT |
| 04/28/2011 | WO2011048208A1 Causal therapy of diseases or conditions associated with cns or pns demyelination |
| 04/28/2011 | WO2011048201A1 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease |
| 04/28/2011 | WO2011048153A1 Novel acylpiperazinones and their use as pharmaceuticals |
| 04/28/2011 | WO2011048150A1 Use of 1h-quinazoline-2,4-diones |
| 04/28/2011 | WO2011048148A2 Glycoside derivative and uses thereof |
| 04/28/2011 | WO2011048125A1 Oral delivery of therapeutically effective lna oligonucleotides |
| 04/28/2011 | WO2011048112A1 Glycoside derivatives and uses thereof |
| 04/28/2011 | WO2011048111A1 Compounds |
| 04/28/2011 | WO2011048082A1 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors |
| 04/28/2011 | WO2011048070A1 Methods and pharmaceutical compositions for the treatment of disorders of glucose homeostasis |
| 04/28/2011 | WO2011048040A1 Method and formulation for the control of parasites |
| 04/28/2011 | WO2011048033A2 Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
| 04/28/2011 | WO2011048032A1 Diazepam derivatives as modulators of chemokine receptors |
| 04/28/2011 | WO2011048018A1 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| 04/28/2011 | WO2011048004A1 Inhibitors of the microsomal prostaglandin e2 synthase-1 |
| 04/28/2011 | WO2011047860A1 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives |
| 04/28/2011 | WO2011047814A1 Pharmaceutical compositions for treating infections with drug resistant mycobacteria |
| 04/28/2011 | WO2011047796A1 Substituted halophenoxybenzamide derivatives |
| 04/28/2011 | WO2011047795A1 Substituted benzosulphonamides |
| 04/28/2011 | WO2011047788A1 Substituted benzosulphonamides |
| 04/28/2011 | WO2011047770A2 Pyrazolopyrimidine derivatives |
| 04/28/2011 | WO2011047767A1 Novel polymorphic forms of (s)-2-[-4-(3-fluoro-benzyloxy)-benzylamino]-propionamide mesylate salt and processes of manufacturing thereof |
| 04/28/2011 | WO2011047700A1 Pharmaceutical compositions of sevelamer |
| 04/28/2011 | WO2011047639A1 Pharmaceutical solution of taxanes comprising chelating agent and preparation method thereof |
| 04/28/2011 | WO2011047637A1 Pharmaceutical solution of taxanes comprising ph regulator and preparation method thereof |
| 04/28/2011 | WO2011047636A1 Pharmaceutical solution of taxanes comprising solubilizer and preparation method thereof |
| 04/28/2011 | WO2011047597A1 Dihydroxy benzopyranone compounds, medical compositions thereof, and their use for treating and preventing fracture and osteoporosis |
| 04/28/2011 | WO2011047596A1 Use of hydroxy benzopyrone compounds for preparing medicine useful for for precaution and treatment of fracture and osteoporosis |
| 04/28/2011 | WO2011047595A1 Use of hydroxy benzopyrone compounds in preparing medicine useful for treating leukemia |
| 04/28/2011 | WO2011047576A1 Use of albiflorin for anti-depression |
| 04/28/2011 | WO2011047530A1 Carotenoid derivatives, preparation method and use thereof |
| 04/28/2011 | WO2011047529A1 Use of flavonoid glycoside compounds in manufacturing medicaments for treating malaria |
| 04/28/2011 | WO2011047518A1 Enteral nutrition comprising marine bioactive polysaccharide, preparation method and use thereof |
| 04/28/2011 | WO2011047515A1 Indenoisoquinolinone derivatives, manufacturing method and medical use thereof. |
| 04/28/2011 | WO2011047481A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/28/2011 | WO2011047466A1 Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents |
| 04/28/2011 | WO2011047439A1 Novel parasite therapy |
| 04/28/2011 | WO2011047434A1 A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011047422A1 Anti-acne composition and use thereof |
| 04/28/2011 | WO2011047421A1 Antifungal composition and method of treatment of dermatitis |
| 04/28/2011 | WO2011047420A1 Cosmetic compositions |
| 04/28/2011 | WO2011047412A1 Tyrosine and l-dopa for reducing l-dopa incorporation into proteins |
| 04/28/2011 | WO2011027060A3 Oxytocin treatment for behavioral characteristics associated with autism and shyness disorder |
| 04/28/2011 | WO2011021224A3 Improved process for preparing (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-(tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate |
| 04/28/2011 | WO2011021218A3 Process for preparing 4-[3, 5-bis (2-hydroxyphenyl)-lh-l, 2, 4- triazol-i-yl] benzoic acid and its amine salts |
| 04/28/2011 | WO2011019326A3 Solubility and stability enchancing pharmaceutical formulation |
| 04/28/2011 | WO2011018532A3 Steroid solvates |
| 04/28/2011 | WO2011015953A3 Greater utility with thyroid hormone |
| 04/28/2011 | WO2011014009A3 Novel di-substituted phenoxyacetyl-based compound or pharmaceutically acceptable salt thereof, production method for same and pharmaceutical composition for suppressing multiple drug resistance comprising same as an active ingredient |
| 04/28/2011 | WO2011012990A8 Improved pharmacokinetics of s-adenosylmethionine formulations |
| 04/28/2011 | WO2011009531A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 04/28/2011 | WO2011009529A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
| 04/28/2011 | WO2011009084A3 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 04/28/2011 | WO2011008675A3 Catecholamine compounds, compositions, and formulations, and methods of using the same |
| 04/28/2011 | WO2011008543A3 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
| 04/28/2011 | WO2011006070A3 Genetic association of polymorphisms in perilipin (plin) gene with resistance to weight loss |
| 04/28/2011 | WO2011005942A3 Oligonucleotide-based compounds as inhibitors of toll-like receptors |
| 04/28/2011 | WO2011005864A3 Ophtalmic ethyleneoxide butyleneoxide block copolymer compositions |
| 04/28/2011 | WO2011004393A4 Para amino benzoic acid based nanotubes |
| 04/28/2011 | WO2011002424A3 Solubility and stability enchancing pharmaceutical formulation comprising ezetimibe and simvastatin |
| 04/28/2011 | WO2011002422A3 Solubility enhancing pharmaceutical formulation |
| 04/28/2011 | WO2011002103A3 A cycloalkane derivative |
| 04/28/2011 | WO2010150995A3 Compositions for treating drug addiction and improving addiction-related behavior |